Finding infections earlier is only part of the work. At IDWeek 2026, David Weber, MD, MPH, explored how broader surveillance and emerging technologies could help infection preventionists spend more ...

Two experts give an update ahead of the first season with a new mRNA vaccine against flu. An early wave of influenza is being driven by a mutated H1N1 strain that only partly escapes population ...

The letter comes after a year of reprocessing validation testing and a voluntary medical device recall. Today, the U.S. Food & Drug Administration issued a letter to health care providers about the ...

John Rex, MD, CMO of F2G, discusses investigational olorofim’s phase 3 findings, why new antifungals are difficult to develop ...

Brucellosis was identified in approximately 0.6 cases per 100,000 hospital admissions in a retrospective analysis of US ...

Kenya’s Bundibugyo virus response shows why execution, not just planning, determines outcomes, and France reported the first known human Shamonda virus infection. Our roundup also covers brucellosis, ...

France’s first reported human Shamonda virus infection raises questions about transmission and vulnerable patients. Explore what investigators know, what remains uncertain, and why infection ...

Investigators generated all potential resident pairs within each nursing home sweep and classified them as roommates or ...

Inpatient infectious diseases (ID) e-consults were associated with outcomes comparable to those of in-person consultations in ...

An ICU study found that alcohol-based hand rub applied after patient care reduced glove bioburden, while staff raised ...

At IDWeek 2026, Samuel Ntow, MBChB, MPH, discussed research findings of reactive infection screening markers in 18.3% of replacement donor records from rural Ghana, highlighting opportunities for ...

Presented at IDWeek 2026, a living review of 64 studies found the strongest evidence for dengue prevention from mosquito modification, while highlighting substantial uncertainty and research gaps in ...